QurAlis
PrivateLast Round
Series B
Extension
Aug 21, 2025
Total Funding Raised
$155.75M
Company Overview
QurAlis is a biotechnology company focused on developing precision therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, utilizing genetically validated targets to create drugs that directly target disease-causing genetic alterations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QurAlis Comps
Public and private peers based on sector, stage, and business model.
QurAlis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Aug 21, 2025 | ||||
| Series B | Mar 9, 2023 | ||||
| Series A | May 13, 2020 | ||||
| Seed | Apr 5, 2018 |
Key People
Founding team and executive leadership
QurAlis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| EQT Life Sciences | Series B |
| Dolby Family Ventures | Series A, Series B |
| MP Healthcare Venture Management | Series A, Series B, Seed |
| Mitsui Global Investment | Series A, Series B |
| Acks | Seed |
| Droia Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2025
Presenting Phase 1 data for QRL-101, a selective Kv7.2/7.3 ion channel opener.
- Dec 2, 2025
Presenting Phase 1 trial data at the American Epilepsy Society 2025 Annual Meeting.
QurAlis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about QurAlis's valuation, stock price, and market status.
